Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 21;26(18):5718.
doi: 10.3390/molecules26185718.

Polyphenols from Citrus Tacle® Extract Endowed with HMGCR Inhibitory Activity: An Antihypercholesterolemia Natural Remedy

Affiliations

Polyphenols from Citrus Tacle® Extract Endowed with HMGCR Inhibitory Activity: An Antihypercholesterolemia Natural Remedy

Fedora Grande et al. Molecules. .

Abstract

Tacle® is a citrus fruit obtained from the crossbreeding of Clementine and Tarocco cultivars. This fruit retains a promising nutraceutical potential most likely due to a high content in polyphenols, among which the main constituents are the two glycosides naringin and hesperidin. Herein, we evaluated, through an in vitro assay, the capability of Tacle extracts to inhibit the hydroxymethylglutaryl-CoA reductase enzyme, which plays a key role in cholesterol biosynthesis. The results obtained spurred us to investigate whether the anti-enzymatic activity observed may be due to a direct interaction of aglycones naringenin and hesperetin with the enzyme catalytic site. Molecular docking simulations indicated that these two compounds are able to anchor to the protein with binding modes and affinities similar to those found for statins, which represent mainstream medications against hypercholesterolemia. The overall results showed an interesting nutraceutical potential of Tacle, suggesting that its extract could be used for dietary supplementation in the treatment of moderate hypercholesterolemia.

Keywords: anti-enzymatic assays; flavanones; molecular docking.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) Visualization of the tetrameric assembly of the catalytic domains of HMGCR; (B) Schematic representation of the arrangement of the chains (A, B, C, and D) and location of the active sites (1, 2, 3, and 4).
Figure 2
Figure 2
(A) Chemical structure of naringenin (R = H, R’ = OH) and hesperetin (R = OH, R’ = OMe); (BF) Ligand-binding pocket of the active site of HMGCR; ribbons representing protein structural element are shown. The key residues are also indicated. (B) Superimposed binding modes of all the six crystallographic statins: mevastatin (pink), cerivastatin (magenta), simvastatin (dark green), rosuvastatin (purple), fluvastatin (blue), atorvastatin (orange); (C) binding mode of mevastatin; (D) superimposed binding modes of the two flavonoid ligands: naringenin (yellow) and hesperetin (light green); specific binding mode of naringenin (E), hesperetin (F).

Similar articles

Cited by

References

    1. Bhatnagar D., Soran H., Durrington P.N. Hypercholesterolaemia and its management. BMJ. 2008;337:503–508. doi: 10.1136/bmj.a993. - DOI - PubMed
    1. Adhyaru B.B., Jacobson T.A. Safety and efficacy of statin therapy. Nat. Rev. Cardiol. 2018;15:757–769. doi: 10.1038/s41569-018-0098-5. - DOI - PubMed
    1. Zhu B., Qi F., Wu J., Yin G., Hua J., Zhang Q., Qin L. Red Yeast Rice: A systematic review of the traditional uses, chemistry, pharmacology, and quality control of an important Chinese folk medicine. Front. Pharmacol. 2019;10:1449. doi: 10.3389/fphar.2019.01449. - DOI - PMC - PubMed
    1. Kosoglou T., Statkevich P., Johnson-Levonas A., Paolini J.F., Bergman A.J., Alton K.B. Ezetimibe: A review of its metabolism, pharmacokinetics and drug interactions. Clin. Pharmacokinet. 2005;44:467–494. doi: 10.2165/00003088-200544050-00002. - DOI - PubMed
    1. Ray K.K., Bays H.E., Catapano A.L., Lalwani N.D., Bloedon L.T., Sterling L.R., Robinson P.L., Ballantyne C.M. Safety and efficacy of bempedoic acid to reduce LDL cholesterol. N. Eng. J. Med. 2019;380:1022–1032. doi: 10.1056/NEJMoa1803917. - DOI - PubMed

MeSH terms